CPT 88167 Reimbursement & Policy Benchmarks

CPT code 88167 covers a two-step cytopathology workflow in which a lab analyst performs a manual review of a cervical or vaginal cytology slide and then rescreens the same slide using computer-assisted cell selection and review, reporting results with the Bethesda System. This code reflects the integration of automated tools into conventional cytology practice, improving targeted review while maintaining supervised technical performance. Nationally, the code matters as laboratories adopt computer-assisted technologies that can affect workflow, documentation, and payer coverage policies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical and billing context, common modifiers used with lab services, typical sites of service, and what to expect in payer coverage approaches. The publication also outlines benchmarks and policy considerations relevant to laboratories and billing professionals, and summarizes clinical reporting conventions tied to the Bethesda System.

The content is intended for laboratory managers, coding and billing staff, and policy analysts who need a clear national view of how 88167 fits into cytology service delivery, documentation, and payer interactions. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 88167 describes a laboratory procedure in which a qualified lab analyst performs a manual analysis of a cervical or vaginal cytopathology slide and then rescreens the identical slide using computer assistance that provides additional cell selection and review. The analyst conducts the technical component of the test under a physician’s supervision and reports results using the Bethesda System for cervical cytology interpretation.

Service type: Cytopathology slide analysis with manual review followed by computer-assisted rescreening and targeted cell selection.
Typical site of service: Clinical laboratory or pathology lab, often within hospitals, independent diagnostic laboratories, or specialized cytology laboratories.

Clinical Context

A 32-year-old woman presents to a gynecology clinic for routine cervical cancer screening. A clinician collects a cervical cytology specimen (Pap smear) using a liquid-based cytology collection device and sends the slide to the laboratory. In the lab, a cytotechnologist or cytology laboratory analyst performs a manual microscopic review of the cervical or vaginal cytology slide to identify cellular abnormalities. After the manual screen, the analyst rescreens the same slide using computer-assisted cell selection software that highlights fields of interest based on programmed cell characteristics; the analyst performs additional targeted review of highlighted areas. The analyst completes the technical component under the supervision of a pathologist, and the final report is rendered using the Bethesda System terminology (e.g., negative for intraepithelial lesion or malignancy, ASC-US, LSIL, HSIL). Typical site of service is an outpatient clinical laboratory or hospital laboratory with cytopathology services. Typical patient scenario includes routine screening, follow-up of an abnormal prior Pap, or surveillance after treatment for cervical intraepithelial neoplasia where higher sensitivity from combined manual and computer-assisted review is desired. Billing is for the technical laboratory procedure performed by the analyst with computer-assisted rescreening documented and supervised by the reporting physician.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the physician/pathologist interpretation separate from the laboratory technical work.

Taxonomy Code	Specialty	Notes
207RX0400X	Pathology	Pathologists supervise and interpret cytology and sign out reports.
2080P0206X	Cytopathology	Subspecialty of pathology focused on cytologic evaluation; frequent sign-out specialty.
311G00000X	Clinical Laboratory	Laboratory directors and technical staff who oversee cytology testing.
367H00000X	Obstetrics & Gynecology	Ordering clinicians who obtain cervical/vaginal specimens in outpatient settings.
363L00000X	Family Medicine	Primary care providers who perform routine cervical cancer screening and order cytology.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z12.4`	Encounter for screening for malignant neoplasm of cervix	Routine cervical cancer screening indication for Pap/cytology testing.
`N87.0`	Mild cervical dysplasia (CIN I)	Cytology used to detect and monitor low-grade intraepithelial neoplasia.
`N87.1`	Moderate cervical dysplasia (CIN II)	Cytology contributes to detection and triage for further diagnostic procedures.
`N87.2`	Severe cervical dysplasia (CIN III)	Cytology assists in surveillance and post-treatment follow-up.
`R87.610`	Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)	Common cytology finding prompting reflex testing or repeat cytology; relevant to interpretation and reporting.
`R87.619`	Abnormal cytology of cervix, unspecified	Covers other abnormal cytologic findings that require reporting using the Bethesda System.
`Z08`	Encounter for follow-up examination after treatment for malignant neoplasm of cervix	Post-treatment surveillance where cytology with computer-assisted rescreening may be used.
`N72`	Inflammatory disease of cervix uteri	Inflammation may generate cytologic atypia leading to need for careful review and rescreening.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`88142`	Cytopathology, cervical or vaginal (e.g., Pap test), requiring interpretation by a physician, manual screening under the microscope (single or first study)	Often performed as the initial manual screen; `88167` may be billed when the same slide is rescreened with computer assistance in addition to manual review.
`88164`	Cytopathology, cervical or vaginal (e.g., Pap test), requiring interpretation by a physician, automated screening with manual review when performed	Related when an automated primary screen is performed; `88167` differs by specifying manual plus computer-assisted rescreening by the analyst.
`88174`	Cytopathology, cervical or vaginal, requiring interpretation by a physician, preparation and interpretation of a computerized primary screen with manual review (if applicable)	Used for workflows emphasizing computerized primary screening and physician interpretation; may be billed in conjunction depending on payer rules and distinct services.
`88175`	Cytopathology, cervical or vaginal, requiring interpretation by a physician, screening by automated system with manual rescreening and physician review (per slide)	Similar clinical purpose; selection among these codes depends on whether the service is performed by the analyst as a manual screen with computer assistance (`88167`) versus other automated/manual combinations.
`88177`	Cytopathology, cervical or vaginal, requiring interpretation by a physician, automated rescreening with final interpretation	May be used in alternative laboratory workflows where automated rescreening is a distinct billed service following primary review.

OpenPayer

Summary & Overview

CPT 88167: Cervical/Vaginal Cytology Manual Review with Computer-Assisted Rescreen